Schizo Affective Disorder Clinical Trials

13 recruiting

Frequently Asked Questions

Common questions about Schizo Affective Disorder clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 113 of 13 trials

Recruiting
Phase 1Phase 2

Cromoglicate Adjunctive Therapy for Outpatients With Schizophrenia

SchizophreniaSchizo Affective Disorder
Vishwajit Nimgaonkar, MD PhD160 enrolled1 locationNCT03794076
Recruiting
Not Applicable

Non-invasive Brain Stimulation Using Tdcs of the Third (of Many) Visual Pathways

Schizo Affective DisorderSCHIZOPHRENIA 1 (Disorder)
Nathan Kline Institute for Psychiatric Research120 enrolled1 locationNCT07469384
Recruiting
Phase 4

Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder

ObesityWeight LossBipolar I Disorder+3 more
Mayo Clinic100 enrolled1 locationNCT07213466
Recruiting
Not Applicable

Using Transcranial Magnetic Stimulation (TMS) to Understand Hallucinations in Schizophrenia

SchizophreniaSchizo Affective Disorder
Mclean Hospital68 enrolled1 locationNCT05343598
Recruiting
Not Applicable

Visual Perception in Schizophrenia

Schizophrenia DisordersBipolar DisorderSchizo Affective Disorder
University of Rochester84 enrolled1 locationNCT06911931
Recruiting
Phase 2Phase 3

Low Amplitude Pulse Seizure Therapy Versus Standard Ultra-Brief Right Unilateral Electroconvulsive Therapy

Suicidal IdeationMajor Depressive DisorderBipolar Disorder+1 more
Michigan State University30 enrolled1 locationNCT06529029
Recruiting
Not Applicable

iTBS to Enhance Social Cognition in People With Psychosis

SchizophreniaSchizo Affective DisorderSchizophreniform Disorders+1 more
Northwell Health100 enrolled1 locationNCT06118268
Recruiting
Phase 4

Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia

SchizophreniaSchizo Affective Disorder
University of Massachusetts, Worcester50 enrolled1 locationNCT06174116
Recruiting
Phase 1Phase 2

Acetazolamide for Treatment Resistant Schizophrenia

SchizophreniaSchizo Affective Disorder
Vishwajit Nimgaonkar, MD PhD60 enrolled2 locationsNCT04887792
Recruiting
Not Applicable

Cognitive Training for Emotion Regulation in Psychotic Disorders

SchizophreniaSchizo Affective Disorder
University of Georgia70 enrolled1 locationNCT04414215
Recruiting
Phase 1

Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder

SchizophreniaSchizo Affective DisorderBipolar Disorder I+2 more
BioXcel Therapeutics Inc140 enrolled5 locationsNCT05025605
Recruiting
Not Applicable

Critical Time Intervention-Peer Support

SchizophreniaPsychotic DisordersBipolar Disorder+1 more
Lisbon Institute of Global Mental Health - LIGMH60 enrolled3 locationsNCT05945277
Recruiting
Not Applicable

Getting Out of the House: Using Behavioral Activation to Increase Community Participation

SchizophreniaMajor Depressive DisorderBipolar Disorder+1 more
Temple University52 enrolled1 locationNCT06336616